Audited annual filings, TTM ratios and consensus forward estimates
Wall Street price targets and rating actions
Revenue disaggregation per 10-K filing
Annual filings (FY) with consensus forward estimates (hatched)
Current price $60.33
Latest analyst grade actions
| Date | Firm | Action | Previous | New grade |
|---|---|---|---|---|
| Oct 20, 26 | Evercore ISI Group | maintain | In Line | In Line |
| Sep 10, 26 | Wells Fargo | maintain | Equal Weight | Equal Weight |
| Sep 10, 26 | Telsey Advisory Group | maintain | Outperform | Outperform |
| Sep 10, 26 | Truist Securities | maintain | Hold | Hold |
| Sep 10, 26 | Barclays | maintain | Equal Weight | Equal Weight |
| Sep 10, 26 | UBS | maintain | Neutral | Neutral |
| Sep 2, 26 | Telsey Advisory Group | maintain | Outperform | Outperform |
| Jul 7, 26 | Evercore ISI Group | maintain | In Line | In Line |
| Jun 11, 26 | Barclays | maintain | Equal Weight | Equal Weight |
1255 daily bars · split adjusted
Daily · Wilder smoothing
Classic floor pivots from 2026-10-23
Computed from daily OHLCV bars
| Indicator | Value | Type | Action |
|---|---|---|---|
| RSI (14) | 72.59 | Oscillator | Sell |
| Stochastic %K (14, 3, 3) | 92.33 | Oscillator | Sell |
| Williams %R (14) | -14.85 | Oscillator | Sell |
| MACD (12, 26, 9) | 3.07 (Hist 0.63) | Oscillator | Strong Buy |
| Average Directional Index (14) | 40.15 (+DI 38.6 / -DI 8.5) | Trend | Strong Buy |
| EMA 20 | 55.57 | MA | Strong Buy |
| SMA 20 | 54.27 | MA | Strong Buy |
| EMA 50 | 52.14 | MA | Strong Buy |
| SMA 50 | 50.10 | MA | Strong Buy |
| SMA 200 | 52.69 | MA | Strong Buy |
SEC EDGAR filings · last 12 months
| Form | Filed | Accepted | Document |
|---|---|---|---|
| 4 | Sep 16, 2026 | 2026-09-16 18:00:47 | View |
| 4 | Sep 16, 2026 | 2026-09-16 09:15:30 | View |
| 144 | Sep 15, 2026 | 2026-09-15 10:35:16 | View |
| 144 | Sep 15, 2026 | 2026-09-15 10:31:32 | View |
| 144 | Sep 14, 2026 | 2026-09-14 16:07:49 | View |
| 144 | Sep 14, 2026 | 2026-09-14 15:44:47 | View |
| 10-Q | Sep 9, 2026 | 2026-09-09 16:07:25 | View |
| 8-K | Sep 9, 2026 | 2026-09-09 08:02:41 | View |
| 4 | Sep 8, 2026 | 2026-09-08 19:04:42 | View |
| 4 | Sep 8, 2026 | 2026-09-08 19:03:17 | View |
Proxy statement (DEF 14A) disclosures
FY2025 · 10-K disclosure
Stock news · updated daily
Academy Sports and Outdoors (ASO) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Investors interested in stocks from the Leisure and Recreation Products sector have probably already heard of Academy Sports and Outdoors, Inc. (ASO) and Amer Sports, Inc. (AS). But which of these two companies is the best option for those looking for undervalued stocks?
Here is how Academy Sports and Outdoors, Inc. (ASO) and Roku (ROKU) have performed compared to their sector so far this year.
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Company to activate in five select race cities as part of multiyear partnership, culminating in Title Sponsorship of HYROX Houston KATY, Texas, Oct. 21, 2026 /PRNewswire/ -- After announcing its designation as an Official Retail Partner of Centr for Centr x HYROX competition gear earlier this year, Academy Sports + Outdoors ("Academy" or "Company") (Nasdaq: ASO), a leading full-line sporting goods and outdoor recreation retailer is deepening its commitment to this growing fitness trend as an Official Partner of HYROX North America. As part of the multiyear partnership beginning in 2026, Academy will activate in five select race cities as part of the HYROX National Tour in Tampa, Dallas, Nashville, Atlanta and Houston, culminating in its Title Sponsorship of HYROX Houston in 2027.
[url="]Ionis Pharmaceuticals, Inc.[/url] (Nasdaq: IONS) partner GSK today announced that the U.S. Food and Drug Administration (FDA) has approved Hibsago(bepiro
Shares of Academy Sports and Outdoors, Inc. (NASDAQ: ASO - Get Free Report) have been given a consensus recommendation of "Moderate Buy" by the sixteen analysts that are presently covering the firm, MarketBeat Ratings reports. Nine research analysts have rated the stock with a hold recommendation, six have issued a buy recommendation and one has issued
Academy Sports + Outdoors Celebrates Brooks Month with Community Event and Performance-Driven GearPR NewswireKATY, Texas, Sept. 21, 2026Monthlong campaign showc
Reported EPS vs. consensus estimate
| Report date | EPS est. | EPS actual | Surprise | Revenue |
|---|---|---|---|---|
| Sep 9, 2026 | 2.07 | 2.31 | Beat 11.6% | $1.65B |
| Jun 9, 2026 | 0.91 | 0.93 | Beat 2.0% | $1.44B |
| Mar 17, 2026 | 2.03 | 1.97 | Miss -3.0% | $1.72B |
| Dec 9, 2025 | 1.06 | 1.14 | Beat 7.5% | $1.38B |
| Sep 2, 2025 | 2.12 | 1.94 | Miss -8.5% | $1.60B |
| Jun 10, 2025 | 0.87 | 0.76 | Miss -12.2% | $1.35B |
Free float vs. closely held shares
13F institutional holdings are not available in the current data plan.
SEC Form 4 filings
| Date | Insider | Role | Type | Shares @ price | Value |
|---|---|---|---|---|---|
| Sep 14, 26 | Johnson Samuel J | officer: President | M-Exempt | 25,580 @ $26.99 | $690.4K |
| Sep 14, 26 | Johnson Samuel J | officer: President | S-Sale | 25,580 @ $53.95 | $1.38M |
| Sep 15, 26 | Johnson Samuel J | officer: President | S-Sale | 27,370 @ $52.82 | $1.45M |
| Sep 15, 26 | Johnson Samuel J | officer: President | S-Sale | 9,123 @ $51.85 | $473.0K |
| Sep 15, 26 | Johnson Samuel J | officer: President | S-Sale | 33,810 @ $50.95 | $1.72M |
| Sep 14, 26 | Johnson Samuel J | officer: President | M-Exempt | 25,580 @ $26.99 | $690.4K |
| Sep 15, 26 | Marley Brian T | director | S-Sale | 3,932 @ $54.00 | $212.3K |
| Sep 15, 26 | Marley Brian T | director | S-Sale | 6,500 @ $52.80 | $343.2K |
TTM vs. 5-year historical average (annual ratios)
| Metric | ASO | Historical (5Y) / ref | Status |
|---|---|---|---|
| P/E ratio (TTM) | 9.9x | 8.1x · sector 73.6x | Discount |
| Forward P/E (FY27E) | 9.0x | EPS est. 6.72 | In line |
| Price / Book | 1.7x | 2.2x | Discount |
| Price / Sales | 0.6x | 0.6x | In line |
| EV / EBITDA | 7.4x | 6.8x | In line |
| Return on equity | 18.4% | — | Healthy |
| Gross margin | 35.8% | 34.5% | In line |
| Debt / Equity | 0.90 | 0.99 | Moderate |
| Piotroski / Altman Z | 7/9 | Z 2.85 | Grey zone |
Discounted cash flow model